Handelsbanken Fonder Ab Avanos Medical, Inc. Transaction History

Handelsbanken Fonder Ab

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 07, 2023	BUY	$19.88 - $27.37 $163,334 - $224,871	8,216 New	8,216 $222,000
Q2 2022 Aug 03, 2022	SELL	$24.87 - $34.68 $241,636 - $336,950	-9,716 Closed	0 $0
Q4 2021 Feb 08, 2022	SELL	$29.25 - $36.02 $134,550 - $165,692	-4,600 Reduced 32.13%	9,716 $337,000
Q2 2021 Aug 03, 2021	BUY	$36.37 - $45.72 $225,493 - $283,464	6,200 Added 76.39%	14,316 $521,000
Q2 2020 Aug 13, 2020	BUY	$23.48 - $33.86 $190,563 - $274,807	8,116 New	8,116 $239,000

276

42.5M

5.4K

Ticker AVNS
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 46,487,000
Market Cap $891M
Description
Avanos Medical, Inc., a medical technology company, focuses on delivering medical device solutions in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. It offers a portfolio of chronic care products that include digestive health products, such as Mic-Key enteral feeding tubes, Corpak patient feeding solutions, ...

Get notified when there are updates to the investment portfolio of Handelsbanken Fonder Ab, based on Form 13F filings with the SEC.

Stay updated on Handelsbanken Fonder Ab with notifications on news.